NO308828B1 - Farmasøytisk preparat - Google Patents

Farmasøytisk preparat

Info

Publication number
NO308828B1
NO308828B1 NO954546A NO954546A NO308828B1 NO 308828 B1 NO308828 B1 NO 308828B1 NO 954546 A NO954546 A NO 954546A NO 954546 A NO954546 A NO 954546A NO 308828 B1 NO308828 B1 NO 308828B1
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
high dose
mycophenolic acid
mycophenolate mofetil
dose oral
Prior art date
Application number
NO954546A
Other languages
English (en)
Norwegian (no)
Other versions
NO954546D0 (no
NO954546L (no
Inventor
Glenn Jay Samuels
Jung-Chung Lee
Charles Lee
Stephen Berry
Paul Joseph Jarosz
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO954546D0 publication Critical patent/NO954546D0/no
Publication of NO954546L publication Critical patent/NO954546L/no
Publication of NO308828B1 publication Critical patent/NO308828B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO954546A 1993-05-13 1995-11-10 Farmasøytisk preparat NO308828B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/061,656 US5455045A (en) 1993-05-13 1993-05-13 High dose formulations
PCT/US1994/005196 WO1994026266A1 (en) 1993-05-13 1994-05-10 High dose formulations

Publications (3)

Publication Number Publication Date
NO954546D0 NO954546D0 (no) 1995-11-10
NO954546L NO954546L (no) 1995-11-10
NO308828B1 true NO308828B1 (no) 2000-11-06

Family

ID=22037233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954546A NO308828B1 (no) 1993-05-13 1995-11-10 Farmasøytisk preparat

Country Status (23)

Country Link
US (3) US5455045A (cs)
EP (1) EP0697866B1 (cs)
JP (1) JP3584037B2 (cs)
KR (1) KR100296214B1 (cs)
CN (1) CN1045884C (cs)
AT (1) ATE187067T1 (cs)
AU (1) AU674960B2 (cs)
BR (2) BR9406604A (cs)
CZ (1) CZ285297B6 (cs)
DE (1) DE69421918T2 (cs)
DK (1) DK0697866T3 (cs)
ES (1) ES2138661T3 (cs)
FI (1) FI114286B (cs)
GR (1) GR3032021T3 (cs)
HU (2) HU226470B1 (cs)
IL (1) IL109639A (cs)
NO (1) NO308828B1 (cs)
NZ (1) NZ266683A (cs)
PL (1) PL175583B1 (cs)
PT (1) PT697866E (cs)
RU (1) RU2135182C1 (cs)
TW (1) TW434010B (cs)
WO (1) WO1994026266A1 (cs)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002520A1 (en) * 1989-08-17 1991-03-07 Cortecs Limited Pharmaceutical formulations
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6479496B1 (en) * 1998-09-10 2002-11-12 Cv Therapeutics, Inc. Methods for treating angina with ranolazine
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
EP2033633A3 (en) 2000-02-18 2009-07-08 Cv Therapeutics, Inc. Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
AU2001239827A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
US6451798B2 (en) 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
AU2001238590A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted piperazine compounds
US6677336B2 (en) 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
US6552023B2 (en) 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
US6573264B1 (en) 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
BR0311161A (pt) * 2002-05-21 2005-03-29 Cv Therapeutics Inc Método de tratamento de diabetes
CA2508608A1 (en) * 2002-12-05 2004-06-24 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
ATE443058T1 (de) * 2003-01-03 2009-10-15 Cv Therapeutics Inc Substituierte heterozyklische verbindungen
KR20050092424A (ko) * 2003-01-17 2005-09-21 씨브이 쎄러퓨틱스, 인코포레이티드 심혈관 질환의 치료에 유용한 치환된 헤테로고리 화합물
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
US20050187170A1 (en) * 2003-06-16 2005-08-25 Biocryst Pharmaceuticals, Inc. Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
KR20060065586A (ko) * 2003-06-23 2006-06-14 씨브이 쎄러퓨틱스, 인코포레이티드 지방산 산화 저해제로서의, 피페라진 및 피페리딘의 우레아유도체
AU2004303882A1 (en) 2003-12-18 2005-07-07 Gilead Palo Alto, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
TW200613294A (en) * 2004-04-26 2006-05-01 Teva Gyogyszergyar Reszvenytarsasag Process for preparation of mycophenolic acid and ester derivatives thereof
EP1740563A2 (en) * 2004-04-27 2007-01-10 Teva Gyógyszergyár Zártköruen Muködo Részvenytarsaság Mycophenolate mofetil impurity
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
ES2340184T3 (es) * 2004-07-20 2010-05-31 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Micofenolato sodico cristalino.
EP1789407A2 (en) * 2004-09-08 2007-05-30 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
US20060177502A1 (en) * 2005-01-06 2006-08-10 Srikonda Sastry Sustained release pharmaceutical formulations
CN100393312C (zh) * 2005-04-18 2008-06-11 吴建梅 霉酚酸或其类似物的软胶囊及其制备方法
US20080281111A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
JP2009542605A (ja) * 2006-07-06 2009-12-03 アレス トレーディング ソシエテ アノニム アニリノ−ピリミジンの経口医薬組成物、その製法、及びその使用
EP2051583A4 (en) * 2006-08-16 2011-09-14 Aspreva Pharmaceuticals Ltd COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE AND INFLAMMATORY DISEASES
WO2008101008A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of coronary microvascular diseases
EP2117550A1 (en) * 2007-02-13 2009-11-18 CV Therapeutics Inc. Use of ranolazine for the treatment of non-coronary microvascular diseases
US20090111826A1 (en) * 2007-02-13 2009-04-30 Louis Lange Use of ranolazine for the treatment of cardiovascular diseases
EP2117508A1 (en) 2007-02-13 2009-11-18 CV Therapeutics Inc. Intravenous solutions comprising ranolazine
US20080233191A1 (en) * 2007-03-22 2008-09-25 Brent Blackburn Use of ranolazine for elevated brain-type natriuretic peptide
KR20100033490A (ko) * 2007-05-31 2010-03-30 질레드 팔로 알토 인코포레이티드 상승된 뇌-형 나트륨이뇨 펩티드에 대한 라놀라진
US20090076000A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched mycophenolate mofetil
AR068745A1 (es) * 2007-10-08 2009-12-02 Panacea Biotec Ltd Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos
WO2009100380A1 (en) * 2008-02-06 2009-08-13 Cv Therapeutics, Inc. Use of ranolazine for treating pain
CN102099029A (zh) * 2008-07-09 2011-06-15 阿斯普瑞瓦国际公司 治疗眼部病症的霉酚酸钠的pH值特定溶液
US9012192B2 (en) * 2008-08-26 2015-04-21 Intelligentnano Inc. Ultrasound enhanced growth of microorganisms
US9005942B2 (en) 2008-08-26 2015-04-14 Intelligentnano Inc. Enhanced animal cell growth using ultrasound
US8962290B2 (en) 2008-08-26 2015-02-24 Intelligentnano Inc. Enhanced animal cell growth using ultrasound
MX2011012140A (es) * 2009-05-14 2012-02-28 Gilead Sciences Inc Ranolazina para el tratamiento de problemas del snc.
EP3351240B1 (en) * 2009-05-19 2019-04-10 Celgene Corporation Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
EP2515880B1 (en) 2009-05-28 2019-11-27 Lupin Limited Novel pharmaceutical compositions of ranolazine
BR112012006433A2 (pt) 2009-09-25 2016-04-19 Lupin Ltd composição de libertação sustentada de ranolazina
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
TW201215392A (en) 2010-06-16 2012-04-16 Gilead Sciences Inc Use of ranolazine for treating pulmonary hypertension
EP4219005A4 (en) 2020-09-27 2024-04-24 China Petroleum & Chemical Corporation DISMUTATION AND TRANSALKYLATION CATALYST, ITS PREPARATION AND ITS APPLICATION
CN114456835B (zh) 2020-10-22 2023-06-06 中国石油化工股份有限公司 一种汽油组分的处理系统和处理方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
JPS5542995B2 (cs) * 1972-02-24 1980-11-04
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
US3903071A (en) * 1973-05-22 1975-09-02 Lilly Co Eli Mycophenolic acid derivatives
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4145918A (en) * 1976-09-07 1979-03-27 Akzona Incorporated Freeze-thaw indicator
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
CA1125698A (en) * 1978-03-09 1982-06-15 Masaru Yoshida Process for preparing a polymer composition
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US5175000A (en) * 1987-06-30 1992-12-29 Vipont Pharmaceutical, Inc. Free amine benzophenanthridine alkaloid compositions
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
AU5419690A (en) * 1989-03-31 1990-11-05 Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
ATE119766T1 (de) * 1989-10-26 1995-04-15 Nippon Shinyaku Co Ltd Zubereitung für den magen.
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
ES2118087T3 (es) * 1990-08-10 1998-09-16 Anormed Inc Composiciones inmunosupresoras.
US5247083A (en) * 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
US5380879A (en) * 1994-02-18 1995-01-10 Syntex (U.S.A.) Inc. Derivatives of mycophenolic acid
US5467037A (en) * 1994-11-21 1995-11-14 International Business Machines Corporation Reset generation circuit to reset self resetting CMOS circuits

Also Published As

Publication number Publication date
HU211270A9 (en) 1995-11-28
AU674960B2 (en) 1997-01-16
CZ285297B6 (cs) 1999-06-16
DE69421918D1 (de) 2000-01-05
FI955439A0 (fi) 1995-11-10
IL109639A (en) 1998-02-08
WO1994026266A1 (en) 1994-11-24
HUT72978A (en) 1996-06-28
RU2135182C1 (ru) 1999-08-27
JP3584037B2 (ja) 2004-11-04
US5472707A (en) 1995-12-05
NO954546D0 (no) 1995-11-10
DE69421918T2 (de) 2000-03-30
CZ295495A3 (en) 1996-02-14
HU226470B1 (en) 2008-12-29
HU9503224D0 (en) 1996-01-29
EP0697866B1 (en) 1999-12-01
EP0697866A1 (en) 1996-02-28
ES2138661T3 (es) 2000-01-16
AU6830194A (en) 1994-12-12
ATE187067T1 (de) 1999-12-15
GR3032021T3 (en) 2000-03-31
JPH08510254A (ja) 1996-10-29
DK0697866T3 (da) 2000-04-17
PL311654A1 (en) 1996-03-04
US5455045A (en) 1995-10-03
PL175583B1 (pl) 1999-01-29
CN1045884C (zh) 1999-10-27
PT697866E (pt) 2000-04-28
NZ266683A (en) 1996-08-27
KR960702304A (ko) 1996-04-27
CN1122571A (zh) 1996-05-15
FI955439L (fi) 1995-11-10
US5554384A (en) 1996-09-10
TW434010B (en) 2001-05-16
FI114286B (fi) 2004-09-30
IL109639A0 (en) 1994-08-26
KR100296214B1 (ko) 2001-10-24
BR9406604A (pt) 1996-01-02
NO954546L (no) 1995-11-10
BR1100723A (pt) 2000-04-18

Similar Documents

Publication Publication Date Title
NO308828B1 (no) Farmasøytisk preparat
NO903264L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av mikropartikler.
NO871790L (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO863670L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
NO177126C (no) Fremgangsmåte for fremstilling av et væskeformig farmasöytisk preparat for oral administrering
DK183585A (da) Iminothiazolidinderivater, deres fremstilling og farmaceutiske praeparater deraf
NO801759L (no) Farmasoeytisk tilberedning for oral administrasjon samt fremgangsmaate for fremstilling av tilberedningen
CA2162670A1 (en) High dose formulations of mycophenolate mofetil, mycophenolic acid and ranolazine
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
FI841739A0 (fi) Heterocyklyllaogalkyl-penem- foereningar, dessa foereningar innehaollande farmaceutiska preparat och anvaendning av de sistnaemnda.
IT1150194B (it) Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva
IT8026232A0 (it) Composizioni farmaceutiche. derivato dell'alfa-mercapto propionilglicina ad attivita'terapeutica, procedimento per lasua preparazione e relative
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
DE3670083D1 (de) Pharmazeutische pyrrolizidinverbindungen und -zusammensetzungen und ihre herstellung.
IT8219453A0 (it) Composizione farmaceutica adattivita' analgesica, antipiretica e antiinfiammatoria e procedimento per la preparazione del principio attivo.
IT8422445A0 (it) Composti antiinfiammatori ed analgesici, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8719352A0 (it) Nuovi composti ad attivita'colinergica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
ATE47399T1 (de) Carboxyalkyldipeptide, deren herstellung und deren pharmazeutische zusammensetzungen.
IT8321017A0 (it) Composto ad attivita'analgesica, antiinfiammatoria e antipiretica, procedimento per lasua preparazione e composizioni farmaceutiche relative.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8723292A0 (it) Loro preparazione e relative composti ad attivita' spasmolitica, composizioni farmaceutiche.

Legal Events

Date Code Title Description
MK1K Patent expired